#scinjection

Live, measured metrics for the hashtag #scinjection from the open social web. Every number carries a named source and the time it was fetched. Nothing is estimated.

hashtag.org network · sponsored

Own #scinjection

This #name is available to claim. It becomes your portal on the open agent web: this very page, a keyword you rank for by an open public stake, and a verifiable identity for AI agents. Nobody else sells a page like this for every #name.

$10.85/ year · 11-character #name
Claim #scinjection — $10.85/yr→Buy on hashtag.space (web3)
card via hashtag.org · tokens via hashtag.space
0
Uses / 7 days
Mastodon
0
Accounts / 7 days
Mastodon
3
Recent posts
Mastodon
~0/hr
Recent pace
Mastodon · last 3
0
Avg reactions / post
Mastodon · last 3

Day-by-day usage

measured · mastodon.online (Mastodon public tags API) · fetched 2026-07-29 13:15 UTC
0
07-23
0
07-24
0
07-25
0
07-26
0
07-27
0
07-28
0
07-29

0 uses by 0 unique accounts across the window. Real per-day counts, not estimates. Newest bar is today so far.

Related hashtags

measured · mas.to (Mastodon public search API) · fetched 2026-07-29 13:15 UTC

No related tags with measured usage found for #scinjection.

Live pulse

measured · mas.to (Mastodon tag timeline) · fetched 2026-07-29 13:15 UTC

Everything below is measured over the latest 3 public posts (spanning ~397 hours).

Posting hours (UTC)

00:0012:0023:00

Languages: English (3)

Avg boosts / post: 0

Top of the latest posts

  • Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Sanofi Winthrop Industrie Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approva

    France@[email protected]♥ 0↻ 02026-07-06 01:00 UTCView post →

  • Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Sanofi Winthrop Industrie Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approva

    France@[email protected]♥ 0↻ 02026-06-19 11:50 UTCView post →

  • Press Release: Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Sanofi Winthrop Industrie Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approva

    Japan@[email protected]♥ 0↻ 02026-06-19 11:50 UTCView post →

Every number above is measured from a named public API at the shown fetch time. Nothing is estimated or extrapolated. Platforms that lock their data behind paid APIs are not shown. Agents: the same numbers, as JSON, at /api/hashtags/scinjection